Gregory I. Frost
2009
In 2009, Gregory I. Frost earned a total compensation of $672.8K as President and Chief Executive Officer at Halozyme Therapeutics, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $8,589 |
|---|---|
| Option Awards | $281,512 |
| Salary | $375,000 |
| Other | $7,701 |
| Total | $672,802 |
Frost received $375K in salary, accounting for 56% of the total pay in 2009.
Frost also received $8.6K in non-equity incentive plan, $281.5K in option awards and $7.7K in other compensation.
Rankings
In 2009, Gregory I. Frost's compensation ranked 5,827th out of 9,885 executives tracked by ExecPay. In other words, Frost earned more than 41.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,827 out of 9,885 | 41st |
Division Manufacturing | 2,099 out of 3,690 | 43rd |
Major group Chemicals And Allied Products | 445 out of 866 | 49th |
Industry group Drugs | 291 out of 638 | 54th |
Industry Biological Products, Except Diagnostic Substances | 52 out of 133 | 61st |
Source: SEC filing on March 29, 2012.
Frost's colleagues
We found eight more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2009.
2009
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2009
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
David Ramsay
Halozyme Therapeutics
Vice President Corporate Development
2009
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2009
Michael LaBarre
Halozyme Therapeutics